Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2011

View Archived Issues

Expanded data presented from ORACAL trial of oral versus nasal salmon calcitonin

Study identifies SNPs linked to remission and response to bupropion and placebo for depression

Orexigen receives design requirements from FDA for cardiovascular outcomes trial of Contrave

Results presented from ENCORE 301 study of exemestane plus entinostat in advanced breast cancer

Bristol-Myers Squibb and Ono enter agreement for Orencia and BMS-936558/ONO-4538

Findings disclosed from post hoc subanalysis of SYNCHRONY study

Cyclic lipopeptide shows promise to treat CDI-associated diarrhea in phase II trial

New phase I data disclosed on Pennvax-B HIV vaccine plus Genevax-IL12

European Commission approves Orion's sedative dexdor

Promising results reported on ProtoKinetix antiaging glycopeptide

Enrollment begins in phase III TOviTO program

OX-219 shows promise in patients with opioid dependence

European Commission approves Incivo

University of Pittsburgh presents new anticancer agents

ARIAD Pharmaceuticals advances phase I/II AP-26113 trial

Boehringer Ingelheim discloses novel Mnk inhibitors

Novel anticancer furoxan derivatives synthesized

New histone deacetylase inhibitors prepared by Millennium Pharmaceuticals

Aragon Pharmaceuticals describes new androgen receptor ligands

Nihon Medi-Physics begins phase III trial of imaging agent NMA-78

Repros Therapeutics' study of low-dose oral Proellex advances

Ariel Pharmaceuticals in-licenses lead product for acute migraine from BTG

Trident Pharmaceuticals' HF-1020 enters first-in-human trial

MSD launches Cubicin in Japan

European orphan drug designation granted to Pfizer's TB product candidate

F-647 approved in China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...